Is that the Fuji who won't answer the phone to your CEO who is in deep conversation with multiple prospective partners? (he says). More than 3 years of palming him off.
Maybe Sumi told him they had a peek and it ain't worth it.
If Cymerus was respected by the stem cell industry someone would just buy the whole place. MSB could afford it. SurgCenter could have done it (and for $70M. less) instead of investing in MSB.
Scuttle off back to CYP Sector. You are worse than droll. They badly need you there.
Moderated, page-1007
-
- There are more pages in this discussion • 582 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.06 |
Change
0.030(2.91%) |
Mkt cap ! $1.221B | |||
| Open | High | Low | Value | Volume |
| $1.05 | $1.09 | $1.03 | $5.796M | 5.430M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 15990 | $1.06 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.08 | 48632 | 3 |
View Market Depth
| Last trade - 16.10pm 02/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |